Clinical Trials Browser

Interventional × Recurrence × loncastuximab tesirine × Clear all

NCT06918912 2025-04-09

LORELY

Phase 2 Recruiting

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse